Today, Nuance Pharma ("Nuance") announced that the Hong Kong Drug Office approved Ohtuvayre® (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult ...

We look forward to presenting important new data for Afrezza at this year’s ATTD and contributing to the scientific dialogue around meal-time diabetes management across both adult and pediatric ...

The five youngest billionaires in the world this year are aged between 20 and 22, with a combined net worth of $17.6 billion.

Title: 79594 - Rademikibart monotherapy in adult and adolescent patients with moderate-to-severe atopic dermatitis (AD): A 1-year, phase III, randomized, double-blinded, placebo-controlled trial ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides ...

Chronic respiratory diseases such as asthma account for 4% of all deaths in South Africa and poverty is the main underlying ...

Over the last two years, research has improved the understanding and treatment of disease. Using tools such as gene editing, ...

Today, Monogram Health, the leading multi-specialty provider of in-home, evidence-based care for patients with multiple chronic conditions, announced that Fierce Healthcare selected it as a "Fierce 15 ...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, ...

Today, March 11, 2026, is being observed as No Smoking Day, an annual awareness campaign marked every year on the second Wednesday of March. The day aims to encourage smokers to take a step toward ...

Poor gut health could increase the risk of dying early or being hospitalized by almost 10% for people with heart failure, and in the first year after being admitted to hospital with heart failure, ...